Determination of Escitalopram in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry
A rapid (3.0 min) and sensitive (LLOQ 0.5 ng/mL) analytical method for the quantitation of Escitalopram (ETP) in human plasma is described. The method is based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) using paroxetine as internal standard (I.S.). Sample prepar...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | Articulo Comunicacion |
Lenguaje: | Inglés |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/18130 http://www.latamjpharm.org/resumenes/31/2/LAJOP_31_2_2_2.pdf |
Aporte de: |
id |
I19-R120-10915-18130 |
---|---|
record_format |
dspace |
institution |
Universidad Nacional de La Plata |
institution_str |
I-19 |
repository_str |
R-120 |
collection |
SEDICI (UNLP) |
language |
Inglés |
topic |
Farmacia brazilian volunteers; escitalopram; LC-MS/MS; pharmacokinetics; validation Farmacología Farmacocinética |
spellingShingle |
Farmacia brazilian volunteers; escitalopram; LC-MS/MS; pharmacokinetics; validation Farmacología Farmacocinética Sousa, Carlos E.M. Bonifácio, F. N. Bedor, Danilo C. G. Silva, T. M. Ramos, Virna L.S. Souza Filho, J. P. Leal, Leila B. Oliveira, Amanda T. C. Santana, Davi P. Determination of Escitalopram in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry |
topic_facet |
Farmacia brazilian volunteers; escitalopram; LC-MS/MS; pharmacokinetics; validation Farmacología Farmacocinética |
description |
A rapid (3.0 min) and sensitive (LLOQ 0.5 ng/mL) analytical method for the quantitation of
Escitalopram (ETP) in human plasma is described. The method is based on High-Performance Liquid
Chromatography-Tandem Mass Spectrometry (LC-MS/MS) using paroxetine as internal standard (I.S.).
Sample preparation involved precipitation extraction with acetonitrile. The chromatographic separation
was achieved on a ACE C18 (125 x 4,6 mm) reversed-phase column and a mobile phase containing acetonitrile/water (60:50 v/v, add 0.2 % formic acid), in isocratic conditions. The target analytes were transferred into a triple quadrupole mass spectrometer equipped with an electrospray ionization source for
mass detection. The ion transitions selected for MRM detection were: m/z 325.2 > 109.2 and 330.0 > 192.0
for ETP and I.S., respectively. The assay was linear in the concentration range of 0.5-50 ng/mL. The mean
recovery for ETP was 97.69 %. Intra- and inter-day precision (R.S.D.) were < 10.5 % and <8.2 %, respectively and the accuracy (R.E.) was in the range ± 12.23 %. The method was successfully applied to a single
oral dose pharmacokinetics study in 28 healthy Brazilian human volunteers. |
format |
Articulo Comunicacion |
author |
Sousa, Carlos E.M. Bonifácio, F. N. Bedor, Danilo C. G. Silva, T. M. Ramos, Virna L.S. Souza Filho, J. P. Leal, Leila B. Oliveira, Amanda T. C. Santana, Davi P. |
author_facet |
Sousa, Carlos E.M. Bonifácio, F. N. Bedor, Danilo C. G. Silva, T. M. Ramos, Virna L.S. Souza Filho, J. P. Leal, Leila B. Oliveira, Amanda T. C. Santana, Davi P. |
author_sort |
Sousa, Carlos E.M. |
title |
Determination of Escitalopram in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry |
title_short |
Determination of Escitalopram in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry |
title_full |
Determination of Escitalopram in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry |
title_fullStr |
Determination of Escitalopram in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry |
title_full_unstemmed |
Determination of Escitalopram in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry |
title_sort |
determination of escitalopram in human plasma by high performance liquid chromatography-tandem mass spectrometry |
publishDate |
2012 |
url |
http://sedici.unlp.edu.ar/handle/10915/18130 http://www.latamjpharm.org/resumenes/31/2/LAJOP_31_2_2_2.pdf |
work_keys_str_mv |
AT sousacarlosem determinationofescitalopraminhumanplasmabyhighperformanceliquidchromatographytandemmassspectrometry AT bonifaciofn determinationofescitalopraminhumanplasmabyhighperformanceliquidchromatographytandemmassspectrometry AT bedordanilocg determinationofescitalopraminhumanplasmabyhighperformanceliquidchromatographytandemmassspectrometry AT silvatm determinationofescitalopraminhumanplasmabyhighperformanceliquidchromatographytandemmassspectrometry AT ramosvirnals determinationofescitalopraminhumanplasmabyhighperformanceliquidchromatographytandemmassspectrometry AT souzafilhojp determinationofescitalopraminhumanplasmabyhighperformanceliquidchromatographytandemmassspectrometry AT lealleilab determinationofescitalopraminhumanplasmabyhighperformanceliquidchromatographytandemmassspectrometry AT oliveiraamandatc determinationofescitalopraminhumanplasmabyhighperformanceliquidchromatographytandemmassspectrometry AT santanadavip determinationofescitalopraminhumanplasmabyhighperformanceliquidchromatographytandemmassspectrometry |
bdutipo_str |
Repositorios |
_version_ |
1764820463851143168 |